Report excerpt
eXoZymes’ recent Q3 investor call was, in my view, a genuine inflection point for the company. For the first time, management laid out a clear, commercially driven roadmap that connects near-term revenues, potential multi-billion-dollar exits and a disciplined capital and operating strategy designed to protect and compound shareholder value.
Those who follow Slack Capital are already aware of my extremely bullish stance on eXoZymes, and the Q3 call held last Thursday has only reinforced that conviction. The risk-reward for what I see as a genuinely rare, once-in-a-lifetime biotech investment opportunity has somehow become even more compelling.
Full report available here on Slack Capital's website
eXoZymes Disclaimer
This content references an independent investment research report prepared and published by a third-party organization, Slack Capital. The views, opinions, estimates, forecasts, and conclusions expressed in the report are solely those of the authors and do not reflect the views or positions of eXoZymes. While select members of the management team from eXoZymes were interviewed as part of the creation of this report, eXoZymes did not commission, contribute to, or review the report prior to its publication. The inclusion of this report on our website is for informational purposes only and does not constitute an endorsement, guarantee, or representation of its accuracy, completeness, or relevance. Readers are encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
About Slack Capital
Slack Capital is an Australian investment research publication dedicated to uncovering and sharing a select number of high-impact company reports focused on asymmetric investment opportunities, with a primary focus on commodities, deep technology and breakthrough innovations. At the heart of Slack Capital are in-depth, free company reports, often the result of over 50 hours of research, where all available information on a company is meticulously compiled and filtered into a centralised report. These reports provide an extensive understanding, often including direct conversations with a company’s management team. They serve as the foundation of an investment thesis and sharpen conviction. Please read and understand Slack Capital's General Investment Disclaimer here. More on Slack Capital here.
eXoZymes Safe Harbor
This article includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which are based on certain assumptions and describe the company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely,” “potential,” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this article regarding the company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Actual results could differ materially for a variety of reasons. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of eXoZymes’ quarterly reports on Form 10-Q, annual reports on Form 10-K, and other documents filed by eXoZymes from time to time by the company with the Securities and Exchange Commission. These filings identify and address important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and eXoZymes assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. eXoZymes does not give any assurance that it will achieve its expectations.
.png?width=1024&height=1024&name=ExoZymes%20-%20MDB%20Capital%20(1).png)